Research context may be incomplete or outdated. Mentioned organizations are not confirmed buyers or FileYield customers. This content does not establish demand, a dataset valuation, compliance, or a right to sell data. FileYield lists descriptions and does not inspect underlying files.

Medical

Nuclear Medicine Scans

Buy and sell nuclear medicine scans data. Bone scans, thyroid uptake, MUGA — nuclear imaging data trains AI for rare conditions you can't find on Kaggle.

DICOMNIfTIInterfilePETCTAC pairsSUV maps

No listings currently in the marketplace for Nuclear Medicine Scans.

Find Me This Data →

Overview

What Is Nuclear Medicine Scans Data?

Nuclear medicine scans data comprises diagnostic imaging records from techniques utilizing radioactive materials (radiopharmaceuticals) to visualize and treat medical conditions. This includes bone scans, thyroid uptake studies, MUGA (multigated acquisition) scans, PET (positron emission tomography), and SPECT (single-photon emission computed tomography) imaging. The data captures molecular-level imaging at the cellular level, enabling visualization of physiological processes that conventional imaging cannot detect. Nuclear medicine scan datasets are particularly valuable for training AI models on rare conditions, cardiology applications, oncology diagnostics, and neurological disorders—areas where publicly available training data on platforms like Kaggle remains limited.

Market Data

USD 8.31 billion

Global Nuclear Medicine Equipment Market Size (2030)

Source: MarketsandMarkets

4.6% CAGR

Market Growth Rate (2025–2030)

Source: MarketsandMarkets

USD 2.05 billion

North America Market Value (2023)

Source: Research and Markets

9.9% CAGR

North America Projected Growth (2023–2029)

Source: Research and Markets

USD 469.04 million

Japan Nuclear Imaging Market (2026)

Source: Mordor Intelligence

Who Uses This Data

What AI models do with it.do with it.

01

Oncology & Cancer Diagnosis

AI training for tumor detection, staging, and treatment planning using PET and SPECT scans to identify malignancies at the molecular level.

02

Cardiology & Heart Disease

MUGA scans and cardiac imaging data for developing algorithms that assess ventricular function, myocardial perfusion, and cardiac viability in rare heart conditions.

03

Neurology & Neurological Disorders

Brain imaging datasets for training models to detect neurodegenerative diseases, dementia patterns, and seizure disorders through molecular imaging patterns.

04

Thyroid & Endocrine Conditions

Thyroid uptake studies and thyroid imaging data for AI development in detecting thyroid dysfunction, nodules, and metabolic disorders.

Pricing depends on the proposed terms

We do not have a verified, comparable price for your dataset. Consider the permitted uses, license term, exclusivity, provenance, coverage and quality. A seller asking price is a proposal, not an appraisal or guaranteed sale. Compare prices only when the source, date, currency, unit and license scope are known.

What Buyers Expect

What makes it valuable.valuable.

01

HIPAA Compliance & De-identification

All scan data must be fully de-identified according to HIPAA standards, with removal of all personally identifiable information and strict audit trails for regulatory compliance.

02

Clinical Annotations & Metadata

High-quality labeling including radiologist reports, diagnostic codes, confirmed diagnoses, treatment outcomes, and imaging parameters (isotope type, acquisition protocol, scanner model).

03

Image Quality & Technical Standards

Scans must meet medical-grade quality standards with proper calibration, minimal artifact, appropriate contrast resolution, and standardized file formats (DICOM preferred).

04

Rarity & Clinical Representation

Datasets representing rare conditions, diverse patient demographics, and varied disease severity levels are highly valued. Scans showing atypical presentations and negative cases strengthen training datasets.

05

Longitudinal Data & Follow-up Studies

Serial imaging from the same patients over time, combined with clinical outcomes and treatment response data, increases dataset value for prognostic model development.

Potential applications and organizations

Who's buying.buying.

GE Healthcare Technologies Inc.

Major nuclear medicine equipment manufacturer and imaging services provider actively acquiring datasets for algorithm development and device optimization.

Lantheus Medical Imaging, Inc.

Radiopharmaceutical and nuclear medicine imaging company investing in AI-driven diagnostic tools and clinical decision support systems.

Cardinal Health Inc.

Healthcare services and imaging solutions provider utilizing nuclear medicine data for workflow optimization and clinical research.

Bayer Corporation

Pharmaceutical and healthcare company developing diagnostic imaging agents and AI-assisted treatment planning solutions.

Curium North America

Radiopharmaceutical and nuclear medicine imaging specialist integrating advanced imaging data into clinical decision support and AI platforms.

FAQ

Common questions.questions.

Why is nuclear medicine scan data valuable for AI training when public datasets like Kaggle exist?

Nuclear medicine scans capture rare and complex disease presentations—particularly in cardiology, oncology, and neurology—that are underrepresented in public datasets. The molecular-level imaging provided by PET, SPECT, and bone scans reveals physiological processes that conventional imaging (CT, MRI) cannot detect, making this data uniquely suited for training AI models on conditions requiring precision medicine approaches and rare disease diagnosis.

What modalities are included in nuclear medicine scan datasets?

Key modalities include PET (positron emission tomography), SPECT (single-photon emission computed tomography), bone scans, thyroid uptake studies, MUGA (multigated acquisition) cardiac scans, and gamma camera imaging. Each modality targets specific organ systems and disease processes, from tumor detection to myocardial perfusion assessment to endocrine disorders.

What regulatory and compliance requirements apply to selling nuclear medicine scan data?

All scan data must be fully HIPAA de-identified with complete removal of personally identifiable information. Additional requirements include meeting radioisotope handling regulations, maintaining audit trails for regulatory compliance, obtaining institutional review board (IRB) approval for research use, and ensuring proper chain-of-custody documentation for clinical data.

How does scan annotation affect the value of a nuclear medicine dataset?

High-quality annotation significantly increases dataset value. Buyers expect radiologist reports, confirmed diagnoses, clinical outcomes, treatment responses, imaging parameters (isotope type, scanner model, acquisition protocol), and longitudinal follow-up data. Datasets with atypical presentations, rare conditions, and negative cases (normal scans) are particularly valuable for comprehensive model training.

Sell yournuclear medicine scansdata.

Describe your nuclear medicine scans and the uses you are authorized to offer. Price, legal suitability, and buyer interest require separate evaluation. No match or sale is guaranteed.

Prepare a Listing